NCI, Cray Blaze Through Genome Map

Late last year, while watching a news report that examined the challenges of annotating the human genome sequence, Bill Long had an epiphany. A programmer at Seattle-based Cray Inc., Long realized that many bioinformatics complexities are basically problems of pattern matching--a Cray specialty. So, Long phoned the National Cancer Institute's (NCI) Advanced Biomedical Computing Center (ABCC) and suggested a collaboration. He was well received. Says ABCC director Stan Burt, facility researchers "

Written byJeffrey Perkel
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The key to Long's idea centered on four pieces of hardware found inside each Cray computer. Distinct from the computer's central processing unit, these pieces, when acting in concert, are extraordinarily efficient at pattern matching. This hardware and its associated instruction set were first developed for the intelligence community. Most other users of these computers neither know nor care that this hardware exists, says Steve Conway, Cray's corporate communications vice president and head of bioinformatics.

The ABCC already owned millions of dollars worth of high-powered computing equipment, including systems developed by IBM, Compaq, Sun, and Silicon Graphics Inc. These computers aid scientists working on phenomenally complex computational problems, but each has its strengths and weaknesses. None had high-speed, pattern-matching capabilities--except for one.

The initial results from this collaboration were announced July 9 and suggested that Cray computers could provide the horsepower necessary for comprehensive analyses of sequence landmarks. The collaborators ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies